Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
13/11/2023 13:45
Nov 13 (Reuters) - Fresh Tracks Therapeutics Q3 EPS USD 0.32. * Q3 net income USD 2.104 million * Q3 revenue USD 7.944 million
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx